Compass Therapeutics (CMPX) Profit After Tax (2023 - 2025)
Historic Profit After Tax for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to -$14.3 million.
- Compass Therapeutics' Profit After Tax fell 3604.62% to -$14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.8 million, marking a year-over-year decrease of 3778.76%. This contributed to the annual value of -$49.4 million for FY2024, which is 1619.29% down from last year.
- Per Compass Therapeutics' latest filing, its Profit After Tax stood at -$14.3 million for Q3 2025, which was down 3604.62% from -$19.9 million recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Profit After Tax ranged from a high of -$7.8 million in Q1 2023 and a low of -$19.9 million during Q2 2025
- In the last 3 years, Compass Therapeutics' Profit After Tax had a median value of -$13.1 million in 2024 and averaged -$13.0 million.
- In the last 5 years, Compass Therapeutics' Profit After Tax crashed by 518.87% in 2024 and then plummeted by 5419.49% in 2025.
- Over the past 3 years, Compass Therapeutics' Profit After Tax (Quarter) stood at -$13.4 million in 2023, then decreased by 12.06% to -$15.0 million in 2024, then grew by 5.15% to -$14.3 million in 2025.
- Its Profit After Tax was -$14.3 million in Q3 2025, compared to -$19.9 million in Q2 2025 and -$16.6 million in Q1 2025.